TrialJournal of clinical psychopharmacology2014

A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.

Cenk Tek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.